In vitro metabolism of di(2-ethylhexyl) phthalate (DEHP) by various tissues and cytochrome P450s of human and rat

被引:75
作者
Choi, Kyoungju [1 ]
Joo, Hyun [1 ]
Campbell, Jerry L., Jr. [1 ]
Clewell, Rebecca A. [1 ]
Andersen, Melvin E. [1 ]
Clewell, Harvey J., III [1 ]
机构
[1] Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA
关键词
DEHP; In vitro metabolism; Human tissues; Rat tissues; Cytochrome P450; LC-MS/MS; HUMAN LIVER-MICROSOMES; DI-(2-ETHYLHEXYL) PHTHALATE; SPECIES-DIFFERENCES; FETAL TESTIS; HUMAN SPERM; INHIBITION; HYDROLYSIS; ABSORPTION; EXPOSURE; ISOFORMS;
D O I
10.1016/j.tiv.2011.12.002
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
In vitro metabolism of DEHP by subcellular fractions of human brain, intestine, kidney, liver, lung, skin, testis, rat liver and recombinant CYP isoforms of human and rat was investigated using LC-MS/MS. DEHP was rapidly hydrolyzed to mono(2-ethylhexyl) phthalate (MEHP) in 12 microsomal/cytosolic fractions of selected 7 human organs and rat liver but not in microsomal fractions of human brain and human female skin. MEHP was metabolized to CYP-mediated oxidative and dealkylated metabolites in human and rat liver and at a lower rate in human intestine. Measurable amounts of mono(2-ethyl-5-hydroxyhexyl) phthalate (5-OH MEHP), mono(2-ethyl-5-oxohexyl) phthalate (5-Oxo MEHP), mono(2-ethyl-5-carboxypentyl) phthalate (5-carboxy MEPP), mono(2-carboxymethyl-hexyl) phthalate (2-carboxy MMHP) and phthalic acid (PA) were formed by human liver fractions. Human CYP2C9*1, CYP2C19 and rat CYP2C6 were the major CYP isoforms producing 5-OH MEHP and 5-Oxo MEHP metabolites; however, only human CYP2C9*1 and 2C9*2 produced 5-carboxy MEPP from MEHP. Additionally, human CYP3A4 and rat CYP3A2 were the primary enzymes for PA production via heteroatom dealkylation of MEHP. Percent total normalized rates (%TNR) by CYP2C9*1 in human liver microsomes (HLM) were 94%, 98% and 100%, respectively, for 5-OH MEHP, 5-Oxo MEHP, 5-carboxy MEPP, and 76% for PA production by CYP3A4. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:315 / 322
页数:8
相关论文
共 41 条
[1]  
ALBRO PW, 1984, DRUG METAB DISPOS, V12, P742
[2]   METABOLISM OF DI(2-ETHYLHEXYL)PHTHALATE [J].
ALBRO, PW ;
LAVENHAR, SR .
DRUG METABOLISM REVIEWS, 1989, 21 (01) :13-34
[3]   PHARMACOKINETICS, INTERACTIONS WITH MACROMOLECULES AND SPECIES-DIFFERENCES IN METABOLISM OF DEHP [J].
ALBRO, PW ;
CORBETT, JT ;
SCHROEDER, JL ;
JORDAN, S ;
MATTHEWS, HB .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1982, 45 (NOV) :19-25
[4]  
ATSDR, 2002, TOX PROF DI 2 ETH PH
[5]   Estimation of the environmental contamination by phthalic acid esters leaching from household wastes [J].
Bauer, MJ ;
Herrmann, R .
SCIENCE OF THE TOTAL ENVIRONMENT, 1997, 208 (1-2) :49-57
[6]   Levels of seven urinary phthalate metabolites in a human reference population [J].
Blount, BC ;
Silva, MJ ;
Caudill, SP ;
Needham, LL ;
Pirkle, JL ;
Sampson, EJ ;
Lucier, GW ;
Jackson, RJ ;
Brock, JW .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 (10) :979-982
[7]  
CARTER JE, 1974, DRUG METAB DISPOS, V2, P341
[8]  
Centers for Disease Control and Prevention, 2021, Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables
[9]   Time- and Dose-Related Effects of Di-(2-ethylhexyl) Phthalate and Its Main Metabolites on the Function of the Rat Fetal Testis in Vitro [J].
Chauvigne, Francois ;
Menuet, Arnaud ;
Lesne, Laurianne ;
Chagnon, Marie-Christine ;
Chevrier, Cecile ;
Regnier, Jean-Francois ;
Angerer, Juergen ;
Jegou, Bernard .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2009, 117 (04) :515-521
[10]   Metabolism of chlorpyrifos and chlorpyrifos oxon by human hepatocytes [J].
Choi, Kyoungju ;
Joo, Hyun ;
Rose, Randy L. ;
Hodgson, Ernest .
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2006, 20 (06) :279-291